GlaxoSmithKline yesterday stepped up its expansion into emerging markets, striking an alliance to sell more than 100 drugs of Dr Reddy's, the Indian generic pharmaceuticals maker, in Africa, the Middle East, the Asia Pacific and Latin America.
葛蘭素史克(GSK)昨日加快其進軍新興市場的步伐，該公司與印度非專利藥品製造商Dr Reddy's結盟，將在非洲、中東、亞太及拉美地區銷售後者生產的100多種藥品。
您已閱讀10%（325字），剩餘90%（3017字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。